Sign in
4/A

Changes in Ownership

Candel Therapeutics, Inc. Filed Acc 0000899243-23-005523

Director bought 27,000 shares at an average $1.89 ($51,108)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Martell Christopher Director 2022-12-08 Purchase +3,050 $1.68 $5,124 128,050 I
Martell Christopher Director 2022-12-09 Purchase +23,950 $1.92 $45,984 152,000 I
Open-market purchases · 27,000 sh · avg $1.89 · $51,108
Loading xslF345X03/doc4a.xml…